Correlation of haemostatic abnormalities with tumour stage and characteristics in dogs with mammary carcinoma

Sixty female dogs with untreated mammary carcinoma, comprising equal numbers of dogs in tumour stages I to IV, were evaluated for haemostatic abnormalities using the following tests: platelet count, prothrombin time, activated partial thromboplastin time, thrombin time, plasma activity of factor V,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of small animal practice 1999-07, Vol.40 (7), p.326-331
Hauptverfasser: Stockhaus, C, Kohn, B, Rudolph, R, Brunnberg, L, Giger, U
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 331
container_issue 7
container_start_page 326
container_title Journal of small animal practice
container_volume 40
creator Stockhaus, C
Kohn, B
Rudolph, R
Brunnberg, L
Giger, U
description Sixty female dogs with untreated mammary carcinoma, comprising equal numbers of dogs in tumour stages I to IV, were evaluated for haemostatic abnormalities using the following tests: platelet count, prothrombin time, activated partial thromboplastin time, thrombin time, plasma activity of factor V, VIII and X, plasma concentration of fibrinogen, fibrin monomers and fibrinogen degradation products, and plasma antithrombin III activity. Two‐thirds of all dogs had one or more haemostatic test abnormality of which the likelihood and frequency was increased in those with stage III and IV neoplasia. Haemostatic abnormalities were more frequently observed in dogs which had mammary tumours with distant metastases, extended tumour necrosis, inflammatory carcinomas, tumours fixed to underlying structures, or tumours in which there was penetration of the tumour capsule by tumour cells. As in humans with mammary carcinoma, these haemostatic abnormalities might be used as prognostic indicators, but their clinical importance remains unknown.
doi_str_mv 10.1111/j.1748-5827.1999.tb03090.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69959521</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69959521</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4336-b35959676169fea37623643269130fb4582fca1d4f0ef73dee6e8691372ca9573</originalsourceid><addsrcrecordid>eNqVkU9vFCEYh4mxsdvqV1DiwduM_BtYvJhmta1No21qozfCMMwu6zBUmEm3375MZtP0Wi6EvM_7g_cBgI8YlTivz9sSC7YsqiURJZZSlkONKJKo3L0Ci6fSa7BAiJCCVRgdgqOUtvnImUBvwCFGjDFRkQXwqxCj7fTgQg9DCzfa-pCGfDZQ132IXnducDbBezds4DD6MEaYgbWFum-g2eiozWCjS7klQdfDJqz3tNfe6_gAjY7G9cHrt-Cg1V2y7_b7Mbg9_f57dV5c_jr7sTq5LAyjlBc1rWQlueCYy9ZqKjihnFHCJaaorVkerzUaN6xFthW0sZbb5VQUxGhZCXoMPs25dzH8H20alHfJ2K7TvQ1jUlzm_IrgDH6ZQRNDStG26i666c0KIzXJVls1GVWTUTXJVnvZapeb3-9vGWtvm2ets90MfJ2Be9fZhxdEq4ubk6s8b04o5oSs1-6eEnT8p7igolJ_fp6p66vT69U3-VedZ_7DzLc6KL3Ov6JubwjK2ojMGllFHwFl6Kl5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69959521</pqid></control><display><type>article</type><title>Correlation of haemostatic abnormalities with tumour stage and characteristics in dogs with mammary carcinoma</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Stockhaus, C ; Kohn, B ; Rudolph, R ; Brunnberg, L ; Giger, U</creator><creatorcontrib>Stockhaus, C ; Kohn, B ; Rudolph, R ; Brunnberg, L ; Giger, U</creatorcontrib><description>Sixty female dogs with untreated mammary carcinoma, comprising equal numbers of dogs in tumour stages I to IV, were evaluated for haemostatic abnormalities using the following tests: platelet count, prothrombin time, activated partial thromboplastin time, thrombin time, plasma activity of factor V, VIII and X, plasma concentration of fibrinogen, fibrin monomers and fibrinogen degradation products, and plasma antithrombin III activity. Two‐thirds of all dogs had one or more haemostatic test abnormality of which the likelihood and frequency was increased in those with stage III and IV neoplasia. Haemostatic abnormalities were more frequently observed in dogs which had mammary tumours with distant metastases, extended tumour necrosis, inflammatory carcinomas, tumours fixed to underlying structures, or tumours in which there was penetration of the tumour capsule by tumour cells. As in humans with mammary carcinoma, these haemostatic abnormalities might be used as prognostic indicators, but their clinical importance remains unknown.</description><identifier>ISSN: 0022-4510</identifier><identifier>EISSN: 1748-5827</identifier><identifier>DOI: 10.1111/j.1748-5827.1999.tb03090.x</identifier><identifier>PMID: 10444752</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>abnormal development ; Adenocarcinoma - blood ; Adenocarcinoma - pathology ; Adenocarcinoma - veterinary ; Animals ; Blood Coagulation Factors - isolation &amp; purification ; Blood Coagulation Tests ; Carcinoma - blood ; Carcinoma - pathology ; Carcinoma - veterinary ; characteristics ; disease course ; Dog Diseases - blood ; Dog Diseases - pathology ; Dogs ; Female ; females ; Hemostasis ; incidence ; mammary neoplasms (animal) ; Mammary Neoplasms, Animal - blood ; Mammary Neoplasms, Animal - pathology ; Neoplasm Staging - veterinary ; Reference Values ; Risk</subject><ispartof>Journal of small animal practice, 1999-07, Vol.40 (7), p.326-331</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4336-b35959676169fea37623643269130fb4582fca1d4f0ef73dee6e8691372ca9573</citedby><cites>FETCH-LOGICAL-c4336-b35959676169fea37623643269130fb4582fca1d4f0ef73dee6e8691372ca9573</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1748-5827.1999.tb03090.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1748-5827.1999.tb03090.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10444752$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stockhaus, C</creatorcontrib><creatorcontrib>Kohn, B</creatorcontrib><creatorcontrib>Rudolph, R</creatorcontrib><creatorcontrib>Brunnberg, L</creatorcontrib><creatorcontrib>Giger, U</creatorcontrib><title>Correlation of haemostatic abnormalities with tumour stage and characteristics in dogs with mammary carcinoma</title><title>Journal of small animal practice</title><addtitle>J Small Anim Pract</addtitle><description>Sixty female dogs with untreated mammary carcinoma, comprising equal numbers of dogs in tumour stages I to IV, were evaluated for haemostatic abnormalities using the following tests: platelet count, prothrombin time, activated partial thromboplastin time, thrombin time, plasma activity of factor V, VIII and X, plasma concentration of fibrinogen, fibrin monomers and fibrinogen degradation products, and plasma antithrombin III activity. Two‐thirds of all dogs had one or more haemostatic test abnormality of which the likelihood and frequency was increased in those with stage III and IV neoplasia. Haemostatic abnormalities were more frequently observed in dogs which had mammary tumours with distant metastases, extended tumour necrosis, inflammatory carcinomas, tumours fixed to underlying structures, or tumours in which there was penetration of the tumour capsule by tumour cells. As in humans with mammary carcinoma, these haemostatic abnormalities might be used as prognostic indicators, but their clinical importance remains unknown.</description><subject>abnormal development</subject><subject>Adenocarcinoma - blood</subject><subject>Adenocarcinoma - pathology</subject><subject>Adenocarcinoma - veterinary</subject><subject>Animals</subject><subject>Blood Coagulation Factors - isolation &amp; purification</subject><subject>Blood Coagulation Tests</subject><subject>Carcinoma - blood</subject><subject>Carcinoma - pathology</subject><subject>Carcinoma - veterinary</subject><subject>characteristics</subject><subject>disease course</subject><subject>Dog Diseases - blood</subject><subject>Dog Diseases - pathology</subject><subject>Dogs</subject><subject>Female</subject><subject>females</subject><subject>Hemostasis</subject><subject>incidence</subject><subject>mammary neoplasms (animal)</subject><subject>Mammary Neoplasms, Animal - blood</subject><subject>Mammary Neoplasms, Animal - pathology</subject><subject>Neoplasm Staging - veterinary</subject><subject>Reference Values</subject><subject>Risk</subject><issn>0022-4510</issn><issn>1748-5827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkU9vFCEYh4mxsdvqV1DiwduM_BtYvJhmta1No21qozfCMMwu6zBUmEm3375MZtP0Wi6EvM_7g_cBgI8YlTivz9sSC7YsqiURJZZSlkONKJKo3L0Ci6fSa7BAiJCCVRgdgqOUtvnImUBvwCFGjDFRkQXwqxCj7fTgQg9DCzfa-pCGfDZQ132IXnducDbBezds4DD6MEaYgbWFum-g2eiozWCjS7klQdfDJqz3tNfe6_gAjY7G9cHrt-Cg1V2y7_b7Mbg9_f57dV5c_jr7sTq5LAyjlBc1rWQlueCYy9ZqKjihnFHCJaaorVkerzUaN6xFthW0sZbb5VQUxGhZCXoMPs25dzH8H20alHfJ2K7TvQ1jUlzm_IrgDH6ZQRNDStG26i666c0KIzXJVls1GVWTUTXJVnvZapeb3-9vGWtvm2ets90MfJ2Be9fZhxdEq4ubk6s8b04o5oSs1-6eEnT8p7igolJ_fp6p66vT69U3-VedZ_7DzLc6KL3Ov6JubwjK2ojMGllFHwFl6Kl5</recordid><startdate>199907</startdate><enddate>199907</enddate><creator>Stockhaus, C</creator><creator>Kohn, B</creator><creator>Rudolph, R</creator><creator>Brunnberg, L</creator><creator>Giger, U</creator><general>Blackwell Publishing Ltd</general><scope>FBQ</scope><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199907</creationdate><title>Correlation of haemostatic abnormalities with tumour stage and characteristics in dogs with mammary carcinoma</title><author>Stockhaus, C ; Kohn, B ; Rudolph, R ; Brunnberg, L ; Giger, U</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4336-b35959676169fea37623643269130fb4582fca1d4f0ef73dee6e8691372ca9573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>abnormal development</topic><topic>Adenocarcinoma - blood</topic><topic>Adenocarcinoma - pathology</topic><topic>Adenocarcinoma - veterinary</topic><topic>Animals</topic><topic>Blood Coagulation Factors - isolation &amp; purification</topic><topic>Blood Coagulation Tests</topic><topic>Carcinoma - blood</topic><topic>Carcinoma - pathology</topic><topic>Carcinoma - veterinary</topic><topic>characteristics</topic><topic>disease course</topic><topic>Dog Diseases - blood</topic><topic>Dog Diseases - pathology</topic><topic>Dogs</topic><topic>Female</topic><topic>females</topic><topic>Hemostasis</topic><topic>incidence</topic><topic>mammary neoplasms (animal)</topic><topic>Mammary Neoplasms, Animal - blood</topic><topic>Mammary Neoplasms, Animal - pathology</topic><topic>Neoplasm Staging - veterinary</topic><topic>Reference Values</topic><topic>Risk</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stockhaus, C</creatorcontrib><creatorcontrib>Kohn, B</creatorcontrib><creatorcontrib>Rudolph, R</creatorcontrib><creatorcontrib>Brunnberg, L</creatorcontrib><creatorcontrib>Giger, U</creatorcontrib><collection>AGRIS</collection><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of small animal practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stockhaus, C</au><au>Kohn, B</au><au>Rudolph, R</au><au>Brunnberg, L</au><au>Giger, U</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correlation of haemostatic abnormalities with tumour stage and characteristics in dogs with mammary carcinoma</atitle><jtitle>Journal of small animal practice</jtitle><addtitle>J Small Anim Pract</addtitle><date>1999-07</date><risdate>1999</risdate><volume>40</volume><issue>7</issue><spage>326</spage><epage>331</epage><pages>326-331</pages><issn>0022-4510</issn><eissn>1748-5827</eissn><abstract>Sixty female dogs with untreated mammary carcinoma, comprising equal numbers of dogs in tumour stages I to IV, were evaluated for haemostatic abnormalities using the following tests: platelet count, prothrombin time, activated partial thromboplastin time, thrombin time, plasma activity of factor V, VIII and X, plasma concentration of fibrinogen, fibrin monomers and fibrinogen degradation products, and plasma antithrombin III activity. Two‐thirds of all dogs had one or more haemostatic test abnormality of which the likelihood and frequency was increased in those with stage III and IV neoplasia. Haemostatic abnormalities were more frequently observed in dogs which had mammary tumours with distant metastases, extended tumour necrosis, inflammatory carcinomas, tumours fixed to underlying structures, or tumours in which there was penetration of the tumour capsule by tumour cells. As in humans with mammary carcinoma, these haemostatic abnormalities might be used as prognostic indicators, but their clinical importance remains unknown.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>10444752</pmid><doi>10.1111/j.1748-5827.1999.tb03090.x</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-4510
ispartof Journal of small animal practice, 1999-07, Vol.40 (7), p.326-331
issn 0022-4510
1748-5827
language eng
recordid cdi_proquest_miscellaneous_69959521
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects abnormal development
Adenocarcinoma - blood
Adenocarcinoma - pathology
Adenocarcinoma - veterinary
Animals
Blood Coagulation Factors - isolation & purification
Blood Coagulation Tests
Carcinoma - blood
Carcinoma - pathology
Carcinoma - veterinary
characteristics
disease course
Dog Diseases - blood
Dog Diseases - pathology
Dogs
Female
females
Hemostasis
incidence
mammary neoplasms (animal)
Mammary Neoplasms, Animal - blood
Mammary Neoplasms, Animal - pathology
Neoplasm Staging - veterinary
Reference Values
Risk
title Correlation of haemostatic abnormalities with tumour stage and characteristics in dogs with mammary carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T00%3A14%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correlation%20of%20haemostatic%20abnormalities%20with%20tumour%20stage%20and%20characteristics%20in%20dogs%20with%20mammary%20carcinoma&rft.jtitle=Journal%20of%20small%20animal%20practice&rft.au=Stockhaus,%20C&rft.date=1999-07&rft.volume=40&rft.issue=7&rft.spage=326&rft.epage=331&rft.pages=326-331&rft.issn=0022-4510&rft.eissn=1748-5827&rft_id=info:doi/10.1111/j.1748-5827.1999.tb03090.x&rft_dat=%3Cproquest_cross%3E69959521%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69959521&rft_id=info:pmid/10444752&rfr_iscdi=true